Sanofi

Listed Company
SNYNFCIK 0001121404OTCLarge AcceleratedPharmaceutical PreparationsI0FRFY ends Dec 31
Period
FY 2025
Revenue
Net Income
$7.85B
Total Assets
$126.81B
Equity
Shares Out
1.22B
Op. Cash Flow
+ 13F Filer
SNY$44.64−8.22% · past yearDBEQ Basic
Daily closing prices

Business

Sanofi is an R&D-driven biopharma company that discovers, develops, manufactures, and commercializes medicines and vaccines across specialty care, general medicines, and vaccines franchises. It applies immunology expertise to create treatments and preventive products serving patients worldwide. The company operates primarily through a single Biopharma segment encompassing research, development, production, and commercial operations across all therapeutic franchises and geographies, with recent divestitures including the sale of a controlling stake in Opella consumer healthcare to CD&R in April 2025.

Summary from 20-F filed 2026-02-17

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$7.85B
Total assets$126.81B
Total liabilities
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Holdings (13F)

Portfolio as of 2026-03-31 · 9 positions

Reported AUM
$335.96M
Holdings
9
Top sector
$335.96M

Top sectors

SectorValue% of portfolio
Uncategorized$335.96M100.0%

Top holdings

IssuerTickerSharesValue%
MeiraGTx Holdings plc12.20M$105.63M31.4%
Inhibrx Biosciences, Inc.1.16M$77.85M23.2%
Novavax6.88M$56.01M16.7%
AnaptysBio821.9K$30.38M9.0%
Agomab Therapeutics NV2.78M$29.19M8.7%
MapLight Therapeutics Inc.912.0K$18.54M5.5%
Immuneering Corp2.71M$14.27M4.3%
Eledon815.0K$2.51M0.8%
Q32 Bio Inc.244.1K$1.57M0.5%

Frequently asked questions

What is Sanofi's CIK number?

Sanofi's SEC CIK number is 0001121404 (1121404). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Sanofi's SEC filings?

All of Sanofi's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

Look up any company's CIK number →